Russo A, Lanzafame S, Magnano A, Giannone N, Cosentino S
Dept. of Surgery, University of Catania, Italy.
Scand J Gastroenterol Suppl. 1994;206:20-4. doi: 10.3109/00365529409091416.
The mechanisms underlying duodenal ulcer (DU) recurrence after endoscopically confirmed healing are unclear. We sought to examine histologic differences in healing induced by omeprazole and nizatidine. This also entailed assessing interobserver variation in endoscopic diagnosis and the correlation between endoscopic and histomorphologic healing. We treated 31 DU patients for 4 weeks with either omeprazole (20 mg daily a.m.) or nizatidine (300 mg twice daily). The healing rates of both groups showed no significant differences (86.7% versus 81.2%; p = 0.5). Good mucosal repair rates did not differ significantly (38.5% versus 69.2% respectively; p = 0.5). Endoscopists' agreement over scar type was 0.80, with the chance of agreement 0.70 (k = 0.34 +/- -0.08). The correlation between macroscopic and histologic appearance of scars was fair, but fully significant (r = 0.48; p < 0.05). We conclude that the study was too small to detect significant differences in healing patterns between the two drugs. The wide variation in endoscopic diagnosis suggests that mucosal repair is best assessed by histologic examination of biopsy samples.
内镜确诊愈合后十二指肠溃疡(DU)复发的潜在机制尚不清楚。我们试图研究奥美拉唑和尼扎替丁诱导愈合的组织学差异。这还需要评估内镜诊断中的观察者间差异以及内镜与组织形态学愈合之间的相关性。我们对31例DU患者分别用奥美拉唑(每日上午20mg)或尼扎替丁(每日两次,每次300mg)治疗4周。两组的愈合率无显著差异(86.7%对81.2%;p = 0.5)。良好的黏膜修复率也无显著差异(分别为38.5%对69.2%;p = 0.5)。内镜医师对瘢痕类型的一致性为0.80,一致的概率为0.70(k = 0.34±0.08)。瘢痕的宏观与组织学表现之间的相关性尚可,但具有统计学意义(r = 0.48;p < 0.05)。我们得出结论,该研究规模太小,无法检测出两种药物在愈合模式上的显著差异。内镜诊断的广泛差异表明,通过对活检样本进行组织学检查来评估黏膜修复是最佳方法。